RDY
Dr. Reddy's Laboratories Ltd. Sponsored ADR · NYSE
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website drreddys.com
- Employees(FY) 25863
- ISIN US2561352038
Performance
-1.73%
1W
-4.68%
1M
-9.54%
3M
+2.85%
6M
-1.9%
YTD
+25.75%
1Y
Profile
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; research and development of differentiated formulations; and provides digital healthcare and information technology enabled business support services. The therapeutic categories primarily include gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Investment Analysis Report: RDY
Overview
In this investment analysis report, we will delve into the financial statements of RDY, a pharmaceutical company operating in the Health Technology sector. We will analyze the company's Balance Sheets, Income Statements, and Cashflow Statements over the past three years to gain insights into its valuation...
Technical Analysis of RDY 2024-05-10
Overview:
In the last 5 trading days, the stock price of RDY has shown a downward trend, with decreasing closing prices and increasing trading volumes. The technical indicators across trend, momentum, volatility, and volume categories provide valuable insights into the potential future price movement of RDY stock.
Trend Analysis:
- Moving average...
Recent News & Updates
- 2023-12-14 07:49
- 2023-12-13 18:49
- 2023-12-06 07:00
- 2023-11-02 09:40
- 2023-10-30 07:38
- 2023-10-29 13:08
- 2023-10-29 01:08
- 2023-10-27 13:50
Dr. Reddy’s Q2 FY24 Financial Results(Business Wire)
- 2023-10-27 02:13
Analyst Report: Dr. Reddy's Laboratories Limited(Yahoo Finance)
- 2023-10-27 01:50
Dr. Reddys Q2 FY24 Financial Results(businesswire)
- 2023-10-26 12:00
- 2023-10-04 12:45
- 2023-09-25 21:35
- 2023-09-18 00:45
- 2023-08-31 00:45
- 2023-08-09 19:00
- 2023-07-27 20:02
Dr. Reddy's (RDY) Q1 Earnings and Revenues Beat Estimates(Yahoo Finance)
- 2023-07-26 22:30
- 2023-07-26 00:31
Dr. Reddys Q1 FY24 Financial Results(Yahoo Finance)
- 2023-07-11 22:25
- 2023-06-09 09:45
- 2023-06-08 09:54
Analyst Report: Dr. Reddy's Laboratories Limited(Yahoo Finance)
- 2023-06-07 23:14
Top Healthcare Stocks for June 2023(Yahoo Finance)
- 2023-06-05 19:18
10 Top-Rated Stocks Billionaires Are Loading Up On(Yahoo Finance)
- 2023-06-04 19:00
- 2023-06-04 03:51
The 3 Most Undervalued Value Stocks to Buy in June 2023(Yahoo Finance)
- 2023-05-15 22:22
Analyst Report: Dr. Reddy's Laboratories Limited(Yahoo Finance)
- 2023-05-10 21:58
Dr. Reddy's (RDY) Q4 Earnings and Revenues Beat Estimates(Yahoo Finance)
- 2023-05-09 23:43
Dr. Reddys Q4 & FY23 Financial Results(Yahoo Finance)
- 2023-05-09 21:21
India's Dr Reddy's Labs posts 11-fold jump in Q4 profit(Yahoo Finance)